Pharmacy practice researchers weighing where to submit a manuscript often land on two names fairly quickly: Innovations in Pharmacy and the International Journal of Clinical and Pharmaceutical Innovations, known as IJCPI. Both publish in overlapping territory, and both get compared on the same handful of metrics.
The Innovations in Pharmacy impact factor should always be checked directly through Web of Science, Scopus, or the journal’s own metrics page rather than taken from a single third-party listing, since figures for smaller, specialized journals can vary between sources and change from year to year.
This guide breaks down the innovations in pharmacy impact factor question honestly, covers the five metrics worth checking before you submit anywhere, and compares Innovations in Pharmacy against IJCPI on the factors that actually affect where your research lands and how visible it becomes.
What is the Innovations in Pharmacy Impact Factor
Innovations in Pharmacy is a peer-reviewed journal published by University of Minnesota Libraries Publishing, focused on pharmacy practice, policy, and education. Its impact factor, like that of many specialized practice journals, is best treated as one data point among several rather than a single verdict on quality, since impact factor figures for smaller journals can shift meaningfully year to year and vary depending on which database is reporting them.
Before citing any specific figure in a proposal or CV, confirm the current number directly through the journal’s own metrics page or a recognized index like Web of Science or Scopus, since third-party aggregator sites don’t always agree with each other or with the official source.
5 Key Metrics Every Author Should Check
Impact factor is one useful data point, not the whole picture. These five metrics together give a far more honest read on whether a journal fits your paper, especially for a specialized practice-focused title like this one.
- Indexing status, whether the journal is currently listed in Web of Science, Scopus, or another recognized database, since this changes over time and should be confirmed directly rather than assumed
- Citation trend, whether citations to recent articles are climbing, flat, or declining, which says more about momentum than a single-year snapshot ever could
- Scope alignment, whether your specific topic, pharmacy practice, clinical pharmacology, or health policy, fits what the journal actually publishes regularly rather than what it claims to cover in general terms
- Turnaround time, since a journal with a strong impact factor but a slow review process may not suit a time-sensitive submission tied to a grant deadline or conference
- Acceptance rate and editorial transparency, including how clearly the journal describes its peer review process, editorial board, and any publication fees upfront
Why a Single Number Rarely Tells the Full Story
Smaller, specialized journals like this one often carry lower raw impact factor numbers simply because their audience is narrower by design, not because the research is weaker. A pharmacy practice journal read primarily by working pharmacists and educators will naturally accumulate fewer citations than a broad biomedical title read by thousands of active researchers, even when the individual articles are equally rigorous.
That’s exactly why treating impact factor as a proxy for quality, rather than one input among several, misleads more authors than it helps. A paper aimed squarely at practicing pharmacists may reach its intended audience far more effectively through a focused practice journal than through a higher-impact-factor title that few working clinicians actually read.
How to Read an Impact Factor Correctly
An impact factor is calculated by dividing the citations a journal’s articles received in a given year by the number of citable articles it published in the two prior years. That formula rewards journals with a steady flow of frequently cited work, but it says nothing about how relevant any single article is to your own research question.
Authors comparing pharmacy journals often forget that the calculation window itself can distort year-to-year figures for smaller titles. A journal publishing forty or fifty articles a year will see its impact factor swing more from a handful of highly cited papers than a journal publishing several hundred, which is exactly why a single year’s number deserves some skepticism on its own.
What to Do Before You Submit
- Pull the current metrics directly from the journal’s own website, not just a search result
- Check whether your topic appears regularly in the journal’s last four to six issues
- Ask the editorial office directly about average turnaround time if it isn’t published clearly
- Compare the submission guidelines against your manuscript’s current format before formatting for a second time
- Keep a shortlist of two or three journals rather than fixating on a single target
Innovations in Pharmacy vs. IJCPI: How Do They Compare
Comparing innovations in pharmacy journal directly against the international journal of clinical and pharmaceutical innovations (IJCPI) makes the practical differences easier to weigh than looking at either journal in isolation.
| Factor | Innovations in Pharmacy | IJCPI |
| Publisher | University of Minnesota Libraries Publishing. | Independent open-access publisher. |
| Scope | Pharmacy practice, policy, and education. | Clinical, pharmaceutical, and biomedical sciences. |
| Access model | Open access. | Open access. |
| Typical article types | Original research, case reports, commentaries. | Original research, reviews, case studies, short communications. |
| Indexing note | Verify current Web of Science and Scopus status directly. | Verify current indexing status directly, including UGC-CARE listing. |
Innovations in Pharmacy tends to draw submissions rooted in pharmacy practice and education, the kind of applied case reports that translate directly into classroom or clinic use. A case study on minoxidil mesotherapy protocols, for example, would sit comfortably within that practice-focused scope, illustrating the kind of hands-on clinical content the journal regularly publishes.
IJCPI casts a wider net across clinical, pharmaceutical, and biomedical sciences, which suits authors whose work sits closer to the intersection of multiple disciplines rather than pharmacy practice specifically. Neither journal is a universally better choice, the right fit depends entirely on where your specific manuscript sits on that spectrum.
One practical way to test the fit before submitting is to pull the last two or three issues of each journal and see which one already publishes work closest in structure and topic to your own manuscript. A journal’s stated scope and its actual recent publishing pattern don’t always match perfectly, and the recent issues usually tell you more than the aims-and-scope page alone.
Who Should Consider Innovations in Pharmacy
This journal tends to suit authors whose work translates directly into pharmacy practice, education, or policy, rather than pure laboratory or drug-discovery research. Practicing pharmacists documenting a clinical protocol, pharmacy educators sharing a curriculum innovation, or policy researchers evaluating a specific practice change all tend to find a natural home here.
Researchers working in drug discovery, formulation chemistry, or basic pharmaceutical science are usually better served by a title with a tighter focus on that specific subfield, since Innovations in Pharmacy’s audience skews toward practice and education rather than bench research. Matching your manuscript’s actual content to a journal’s real readership, not just its name, remains the single most reliable filter available.
Here’s What You Need to Know
- A single impact factor number rarely tells the full story for a specialized pharmacy practice journal.
- Confirm current indexing status directly rather than relying on aggregator sites alone.
- Scope fit and turnaround time often matter more than a marginal difference in impact factor.
- Comparing innovations in pharmacy against IJCPI only makes sense once you’ve defined your own priorities as an author.
Final Verdict
The innovations in pharmacy impact factor matters less on its own than it does alongside indexing status, scope fit, and turnaround time, and treating it as the single deciding factor tends to lead authors toward journals that don’t actually fit their paper. Weigh all five metrics together, confirm current figures directly with the journal or a recognized database, and choose based on where your specific research genuinely belongs rather than which title has the highest number attached to it this year.
If you’d like help working through that decision, our team at Scholarly Summit supports authors with journal selection and submission strategy across pharmacy, clinical, and biomedical fields.
Frequently Asked Questions
1. What is the current impact factor of Innovations in Pharmacy?
Figures vary by source and year, so confirm the current number directly through Web of Science, Scopus, or the journal’s own published metrics rather than relying on a single aggregator site.
2. Is Innovations in Pharmacy a peer-reviewed journal
Yes, Innovations in Pharmacy is a peer-reviewed journal published by University of Minnesota Libraries Publishing, covering pharmacy practice, policy, and education.
3. How does Innovations in Pharmacy compare to IJCPI?
Innovations in Pharmacy focuses more narrowly on pharmacy practice and education, while IJCPI covers a broader range of clinical, pharmaceutical, and biomedical topics, so the better fit depends on your specific manuscript.
4. Does a higher impact factor guarantee better visibility for my research?
No. A higher impact factor can help, but scope fit, indexing, and how actively a journal’s audience engages with your specific topic all affect visibility just as much.
5. Why is turnaround time important when choosing a journal like Innovations in Pharmacy?
A strong impact factor doesn’t help if a slow review process delays your research reaching readers, particularly for time-sensitive clinical or practice-based findings.